Diagnostic Assessment of Nonpalpable Breast Cancer-The Difference in Diagnostic Approach for the Clinical Treatment of Breast Cancer Between the Japanese Guidelines and the National Comprehensive Cancer Network (USA) Guidelines
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-10-25
著者
-
NAKAMURA Seigo
Breast Center
-
Nakamura Seigo
Breast Surgical Oncology
-
Tsunoda Shimizu
St Luke's International Hospital Department Of Radiology
関連論文
- Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
- Paclitaxel and SN-38 Overcome Cisplatin Resistance of Ovarian Cancer Cell Lines by Down-regulating the Influx and Efflux System of Cisplatin
- WS3-1 Application of two-color FISH with liquid-based thin-layer cytological preparations for uterine cancers
- P-22 Detection of chromosomal alterations in ovarian cancers using double-targeted FISH
- Application of Double-targeted Fluorescence in situ Hybridization for Cytological Examinations in Gynecological Field.
- Significance of MUC1 mucin expression in clear cell adenocarcinoma of the ovary
- Two Japanese kindreds occurring endometrial cancer meeting new clinical criteria for hereditary non-polyposis colorectal cancer (HNPCC), Amsterdam Criteria II
- Association of HNPCC and endometrial cancers
- Two Soluble Forms of β1,4-Galactosyltransferase Released from Ovarian Cancer Cells and from COS-1 Cells Transfected with its cDNA (Recent Progresses in Carbohydrate Histochemistry)
- Diagnostic Assessment of Nonpalpable Breast Cancer-The Difference in Diagnostic Approach for the Clinical Treatment of Breast Cancer Between the Japanese Guidelines and the National Comprehensive Cancer Network (USA) Guidelines